Metabolic syndrome in young Czech women with polycystic ovary syndrome

被引:51
作者
Vrbíková, J
Vondra, K
Cibula, D
Dvoráková, K
Stanická, S
Srámková, D
Sindelka, G
Hill, M
Bendlová, B
Skrha, J
机构
[1] Inst Endocrinol, Prague 11694 1, Czech Republic
[2] Charles Univ Prague, Dept Obstet & Gynecol, Prague 12000 2, Czech Republic
[3] Charles Univ Prague, Dept Internal Med, Prague 12000 2, Czech Republic
关键词
euglycaemic clamp; insulin resistance; metabolic syndrome; polycystic ovary;
D O I
10.1093/humrep/dei221
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
METHODS: Sixty-nine young women with polycystic ovary syndrome (PCOS) [age 25.2 +/- 4.7 years, with body mass index (BMI) 24.3 +/- 4.8 kg/m(2); mean +/- SD] and 73 age-matched healthy females (BMI 22.3 +/- 3.3 kg/m(2); mean +/- SD) were evaluated for the occurrence of features of metabolic syndrome according to the Adult Treatment Panel III. RESULTS: Overt metabolic syndrome (the presence of three and more risk factors) was not more common in PCOS women (1/64, 1.6%) than in healthy controls (0/73, 0%). On the other hand, in nearly 50% of PCOS women isolated features of metabolic syndrome, most often a decrease in high-density lipoprotein (HDL) cholesterol, were found. Women with at least one feature of metabolic syndrome were, in comparison with women without any of these features, significantly more obese (P = 0.0001), with lower insulin sensitivity (P = 0.05). When comparing PCOS women according to the degree of insulin sensitivity, as determined by euglycaemic clamp, isolated features of metabolic syndrome were found in 8/17 women above the upper quartile, compared with 11/16 women below the lower quartile of insulin sensitivity (P = 0.20). CONCLUSIONS: Overt metabolic syndrome is only rarely encountered in young Czech females affected by PCOS but its isolated features are relatively frequent, both in young PCOS patients and in age-matched control women.
引用
收藏
页码:3328 / 3332
页数:5
相关论文
共 32 条
[1]  
ADAMS JM, 2005, OBSTET GYNECOL SURV, V60, P239
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]   Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome [J].
Apridonidze, T ;
Essah, PA ;
Iuorno, MJ ;
Nestler, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) :1929-1935
[5]   The prevalence and features of the polycystic ovary syndrome in an unselected population [J].
Azziz, R ;
Woods, KS ;
Reyna, R ;
Key, TJ ;
Knochenhauer, ES ;
Yildiz, BO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2745-2749
[6]   HOW COMMON ARE POLYCYSTIC OVARIES IN NORMAL WOMEN AND WHAT IS THEIR SIGNIFICANCE FOR THE FERTILITY OF THE POPULATION [J].
CLAYTON, RN ;
OGDEN, V ;
HODGKINSON, J ;
WORSWICK, L ;
RODIN, DA ;
DYER, S ;
MEADE, TW .
CLINICAL ENDOCRINOLOGY, 1992, 37 (02) :127-134
[7]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[8]   RISK-FACTORS FOR CORONARY-ARTERY DISEASE IN LEAN AND OBESE WOMEN WITH THE POLYCYSTIC-OVARY-SYNDROME [J].
CONWAY, GS ;
AGRAWAL, R ;
BETTERIDGE, DJ ;
JACOBS, HS .
CLINICAL ENDOCRINOLOGY, 1992, 37 (02) :119-125
[9]  
DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214
[10]   Smaller LDL particle size in women with polycystic ovary syndrome compared to controls [J].
Dejager, S ;
Pichard, C ;
Giral, P ;
Bruckert, E ;
Federspield, MC ;
Beucler, I ;
Turpin, G .
CLINICAL ENDOCRINOLOGY, 2001, 54 (04) :455-462